Thursday 28 February 2013 14:00 |
Seminar Discovery of Bitopertin: A potent and selective GlyT1 inhibitor (GRI) for the treatment of Schizophrenia | |
Lecture theatre 1S081 Sciences III ![]() |
Dr Andrew Thomas F. Hoffmann-La Roche AG Pharmaceutical Research, Discovery Chemistry, Basel Org.: Prof. Clement Mazet ![]() ![]() ![]() |
29/05/2023 09:56